PeptideStack
5.2kquestions
20kanswers
220users

Would you accept 99.1% on semaglutide from SGN without a content assay?

Asked 30 Apr 2024Modified 23 months agoViewed 39k times
28

The specifics, since they change the answer: 99.1% · semaglutide · SGN.

I would like to define my thresholds before I have a result, for obvious reasons.

I want a plan with explicit stopping rules, not just steps.

How do I make this decision on evidence rather than on feel?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

438 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
SH
askedseven_day_half16k1830 Apr 2024
3The timing signature is the useful part. Everything else is confounded. – ahmed_zerouali 4 months ago
add a comment

5 Answers

Sorted by votes
16

Mechanically, purity is a method-dependent figure, and that is not a limitation of the measurement, it is a property of what the measurement actually answers.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

Integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

I would be careful about over-reading a single measurement — treat it as a data point, not as ground truth.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

edited 16 Jul 2024 by Dr_Colm_Fitzhenry — corrected a unit error in the worked example

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry85k24811 Jul 2024
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
12

The method matters more than the vial, which is why specifying a method buys you far more than changing suppliers does.

Detection wavelength matters because 214 nm sees the peptide backbone while 280 nm sees only aromatic side chains — so truncation impurities lacking a tryptophan are invisible at 280 nm.

Put another way, sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
BB
answeredbac_or_bust37k13830 Jun 2024
Does this hold at lower concentrations, or does adsorption dominate? – Dr_Priya_Raghunathan 2 months ago
Worth flagging that this changed in 2025, so older answers on the site are out of date. – charge_state_3 10 months ago
add a comment
6

Concretely, reporting threshold is convention and not chemistry, which is why two certificates with different thresholds disagree by a tenth of a point or more.

Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.

Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.

Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
MH
answeredm_haraldsen38k3819 Jun 2024
4Adding for future readers: the certificate should carry the lot number, not just a batch code. – v_ramaswamy 41 days ago
add a comment
3

Understanding purity requires separating the chemistry from the method from the reporting convention, and the three are not independent.

Column pore size affects mass transfer — a 100 Angstrom packing on a 5 kDa peptide restricts diffusion, broadening the peak and potentially hiding small impurities in the shoulders.

Proline conformer interconversion kinetics are well-characterised and the half-life is of the same order as the chromatographic peak width at room temperature.

One qualification: achieving purity above roughly 98 per cent on a 30-residue peptide is fighting the chemistry of synthesis, not the quality of the purification.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
MT
answeredmarcus_thorbjorn16k2825 Aug 2024
Minor: the trial name is hyphenated in the original publication. – b_delacroix 2 months ago
add a comment
-2

Start from what the detector sees, because that tells you what the number means.

Mass on column affects detector linearity and peak overlap — overloading broadens peaks and hides neighbours, while underloading improves resolution but loses sensitivity.

Inter-laboratory studies on identical peptide material routinely find half-a-per-cent to a full-per-cent spreads in reported purity on the same sample.

The limitation is that single-digit micro-impurities become invisible at typical reporting thresholds, so "no impurities detected" means "none above one in two thousand."

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
GI
answeredgunnar_isaksen16k288 Jun 2024
I would gently push back on the second point — the evidence there is thinner than stated. – olu_babatunde 9 months ago
2Adding for future readers: the certificate should carry the lot number, not just a batch code. – Dr_Otto_Lindqvist 36 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.